share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

DA 戴維森在 Usana 健康科學方面保持中立,將價格目標提高至 $52.5
Benzinga Real-time News ·  2023/02/13 23:03

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $49 to $52.5.

Da Davidson分析師Linda Bolton Weiser維持Usana Health Science(紐約證券交易所代碼:USNA)的中性,並將目標價從49美元上調至52.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論